A comparative study to ascertain efficacy of oral antifungal therapy and laser in fungal nail infection.
- Conditions
- Health Condition 1: L608- Other nail disorders
- Registration Number
- CTRI/2020/04/024536
- Lead Sponsor
- Dr Prasenjeet Mohanty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients having one or more toenail and/or fingernail fungal infections of the following types: distal subungual onychomycosis, proximal subungual onychomycosis, superficial white/black onychomycosis, endonyx onychomycosis, total dystrophic type onychomycosis or mixed onychomycosis.
2.Patients with diabetes mellitus, immunocompromised patients, and organ transplant patients will be included, although we consider that these patient groups success rates could be considerably less.
1.Patients who used systemic antifungal or isotretinoin within 6months.
2.Permanent or semi-permanent discoloration of the nail plate (e.g. topical therapeutics, cosmetics or professional dye exposure) as they can cause various physiological changes to the nail plate in addition to discoloration.
3.Subungual hematoma, nevoid subungual formation, bacterial nail infections, and concomitant nail disorders such as psoriasis of nail plate, lichen planus and atopic dermatitis.
4.Fungal infections of other body parts.
5.Any generalized skin disease.
6.Pregnancy.
7.Patients having liver or renal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method % of patients with excellent outcomeTimepoint: December 2019 to December 2020
- Secondary Outcome Measures
Name Time Method 1. Species detection <br/ ><br>2. % of incomplete cure and relapse. <br/ ><br>3. Safety profile of interventionTimepoint: December 2019 to December 2020